ACXP - Acurx spikes after mid-stage data for oral antibiotic
2023-12-11 07:55:55 ET
More on Acurx Pharmaceuticals
- Acurx Pharmaceuticals, Inc. (ACXP) Q3 2023 Earnings Call Transcript
- Acurx Undervalued And Set For Potential M&A With Next-Gen C. Diff Treatment
- Stocks To Watch: Tesla, Netflix, And AT&T Headline Big Week Of Earnings
- Acurx Pharma falls after mid-stage data for lead asset
- Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
For further details see:
Acurx spikes after mid-stage data for oral antibiotic